Back to Search Start Over

Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future.

Authors :
Ogunleye OO
Basu D
Mueller D
Sneddon J
Seaton RA
Yinka-Ogunleye AF
Wamboga J
Miljković N
Mwita JC
Rwegerera GM
Massele A
Patrick O
Niba LL
Nsaikila M
Rashed WM
Hussein MA
Hegazy R
Amu AA
Boahen-Boaten BB
Matsebula Z
Gwebu P
Chirigo B
Mkhabela N
Dlamini T
Sithole S
Malaza S
Dlamini S
Afriyie D
Asare GA
Amponsah SK
Sefah I
Oluka M
Guantai AN
Opanga SA
Sarele TV
Mafisa RK
Chikowe I
Khuluza F
Kibuule D
Kalemeera F
Mubita M
Fadare J
Sibomana L
Ramokgopa GM
Whyte C
Maimela T
Hugo J
Meyer JC
Schellack N
Rampamba EM
Visser A
Alfadl A
Malik EM
Malande OO
Kalungia AC
Mwila C
Zaranyika T
Chaibva BV
Olaru ID
Masuka N
Wale J
Hwenda L
Kamoga R
Hill R
Barbui C
Bochenek T
Kurdi A
Campbell S
Martin AP
Phuong TNT
Thanh BN
Godman B
Source :
Frontiers in pharmacology [Front Pharmacol] 2020 Sep 11; Vol. 11, pp. 1205. Date of Electronic Publication: 2020 Sep 11 (Print Publication: 2020).
Publication Year :
2020

Abstract

Background: The COVID-19 pandemic has already claimed considerable lives. There are major concerns in Africa due to existing high prevalence rates for both infectious and non-infectious diseases and limited resources in terms of personnel, beds and equipment. Alongside this, concerns that lockdown and other measures will have on prevention and management of other infectious diseases and non-communicable diseases (NCDs). NCDs are an increasing issue with rising morbidity and mortality rates. The World Health Organization (WHO) warns that a lack of nets and treatment could result in up to 18 million additional cases of malaria and up to 30,000 additional deaths in sub-Saharan Africa.<br />Objective: Document current prevalence and mortality rates from COVID-19 alongside economic and other measures to reduce its spread and impact across Africa. In addition, suggested ways forward among all key stakeholder groups.<br />Our Approach: Contextualise the findings from a wide range of publications including internet-based publications coupled with input from senior-level personnel.<br />Ongoing Activities: Prevalence and mortality rates are currently lower in Africa than among several Western countries and the USA. This could be due to a number of factors including early instigation of lockdown and border closures, the younger age of the population, lack of robust reporting systems and as yet unidentified genetic and other factors. Innovation is accelerating to address concerns with available equipment. There are ongoing steps to address the level of misinformation and its consequences including fines. There are also ongoing initiatives across Africa to start addressing the unintended consequences of COVID-19 activities including lockdown measures and their impact on NCDs including the likely rise in mental health disorders, exacerbated by increasing stigma associated with COVID-19. Strategies include extending prescription lengths, telemedicine and encouraging vaccination. However, these need to be accelerated to prevent increased morbidity and mortality.<br />Conclusion: There are multiple activities across Africa to reduce the spread of COVID-19 and address misinformation, which can have catastrophic consequences, assisted by the WHO and others, which appear to be working in a number of countries. Research is ongoing to clarify the unintended consequences given ongoing concerns to guide future activities. Countries are learning from each other.<br /> (Copyright © 2020 Ogunleye, Basu, Mueller, Sneddon, Seaton, Yinka-Ogunleye, Wamboga, Miljković, Mwita, Rwegerera, Massele, Patrick, Niba, Nsaikila, Rashed, Hussein, Hegazy, Amu, Boahen-Boaten, Matsebula, Gwebu, Chirigo, Mkhabela, Dlamini, Sithole, Malaza, Dlamini, Afriyie, Asare, Amponsah, Sefah, Oluka, Guantai, Opanga, Sarele, Mafisa, Chikowe, Khuluza, Kibuule, Kalemeera, Mubita, Fadare, Sibomana, Ramokgopa, Whyte, Maimela, Hugo, Meyer, Schellack, Rampamba, Visser, Alfadl, Malik, Malande, Kalungia, Mwila, Zaranyika, Chaibva, Olaru, Masuka, Wale, Hwenda, Kamoga, Hill, Barbui, Bochenek, Kurdi, Campbell, Martin, Phuong, Thanh and Godman.)

Details

Language :
English
ISSN :
1663-9812
Volume :
11
Database :
MEDLINE
Journal :
Frontiers in pharmacology
Publication Type :
Academic Journal
Accession number :
33071775
Full Text :
https://doi.org/10.3389/fphar.2020.01205